Literature DB >> 7821316

Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients--a baseline study.

M O Galal1, A Wobst, Z Halees, L Hatle, A A Schmaltz, F Khougeer, E De Vol, M E Fawzy, F Abbag, F Fadley.   

Abstract

This study intends to provide a detailed overview of the types and rates of peri-operative complications after surgical correction of an isolated ASD II. The transvenous approach to the occlusion of atrial septal defects has yielded promising results during its first 5 years of clinical trials, but before it can be established as a routine measure, definite proof is needed to demonstrate that its rate of serious complications does at least not exceed that of the surgical closure. Between 1985 and 1992, 232 consecutive patients underwent surgical closure of a secundum atrial septal defect. Among the patients 118 were children (< 18 years; 79 girls and 39 boys) with a mean age of 8.9 +/- 5.2 years (4 months-17 years) and 114 adults (74 women and 40 men) with a mean age of 28.5 +/- 10.8 years (18-69 years). Pre-operatively eight children (6.8%) and eight adults (7%) were treated for right heart failure. Mean pulmonary artery pressure was 20.4 +/- 10.4 mmHg for the children and 19.3 +/- 7 mmHg for the adults. The average pulmonary artery to systemic flow ratios were 2.9:1 and 3:1 for children and adults, respectively. Thirty children (25.4%) and 15 adults (13.2%) underwent patch closure while direct suture was the method used for the remaining patients. Average cardiopulmonary bypass time was 35.7 +/- 17.9 min for the children and 41.5 +/- 19.9 min for the adults. The length of the procedure (skin to skin) was a mean of 116 min in the young group, and 141 min in the adult group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7821316     DOI: 10.1093/oxfordjournals.eurheartj.a060398

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings").

Authors:  C Rickers; C Hamm; H Stern; T Hofmann; O Franzen; R Schräder; H Sievert; D Schranz; I Michel-Behnke; J Vogt; D Kececioglu; W Sebening; A Eicken; H Meyer; W Matthies; F Kleber; J Hug; J Weil
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

2.  A plant mitochondrial sequence transcribed in transgenic tobacco chloroplasts is not edited.

Authors:  C A Sutton; O V Zoubenko; M R Hanson; P Maliga
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

3.  Sizing of atrial septal defects to predict successful closure with transcatheter cardioSEAL device.

Authors:  H G El-Said; L I Bezold; R G Grifka; R H Pignatelli; C J McMahon; D A Schutte; E O Smith; C E Mullins
Journal:  Tex Heart Inst J       Date:  2001

Review 4.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

Review 5.  [Interventions in congenital heart disease and their sequelae in adults].

Authors:  A A Schmaltz; U Neudorf; S Sack; O Galal
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

6.  Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost.

Authors:  J D R Thomson; E H Aburawi; K G Watterson; C Van Doorn; J L Gibbs
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

7.  Recent Experience and Follow-Up After Surgical Closure of Secundum Atrial Septal Defect in 120 Children.

Authors:  Geoffroy de Beco; Natasha Mambour; Christophe Vô; Laetitia Vanhoutte; Stéphane Moniotte; Alain Poncelet; Thierry Sluysmans
Journal:  Pediatr Cardiol       Date:  2018-05-22       Impact factor: 1.655

8.  Closure of atrial septal defects in children: surgery versus Amplatzer device implantation.

Authors:  Jacek Bialkowski; Blandyna Karwot; Malgorzata Szkutnik; Pawel Banaszak; Jacek Kusa; Janusz Skalski
Journal:  Tex Heart Inst J       Date:  2004

9.  Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects.

Authors:  Mohammed Numan; Amal El Sisi; Magdi Tofeig; Salwa Gendi; Tohami Tohami; Howaida G El-Said
Journal:  Pediatr Cardiol       Date:  2007-11-13       Impact factor: 1.655

10.  Surgical Management for Complications during Closure of Atrial Septal Defect with Amplatzer Device.

Authors:  Hui-Chung Wu; Chung-Chi Wang; Yun-Chin Fu; Sheng-Lin Jan; Hao-Ji Wei; Yung-Kai Lin; Yen Chang
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.